IDEV (IDEV) Stock Price & Analysis
IDEV (IDEV) rose 0.57% to USD 88.99 as of July 25, 2026 at 20:24 UTC, according to Nexqual real-time market data.
IDEV last closed at USD 88.49; the session ranged USD 88.8–89.45 on volume of 958,099 shares. Market capitalization is —, with a 52-week range of USD 74.22–91.03 (PCX). Source: Nexqual, July 25, 2026 at 20:24 UTC.
Key Statistics (as of July 25, 2026 at 20:24 UTC)
| Price | USD 88.99 |
|---|---|
| Change | ▲ 0.57% (up) |
| Previous Close | USD 88.49 |
| Open | USD 89 |
| Day Range | USD 88.8 – 89.45 |
| 52-Week Range | USD 74.22 – 91.03 |
| Volume | 958,099 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IDEV)
Nexqual's technical model rates IDEV "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 20:24 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 50.31 (neutral) |
| vs SMA50 | Below (USD 89.27) |
| MACD | -0.02 (negative) |
Financial Health Score (IDEV)
Nexqual rates IDEV's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 20:24 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MEDX | Horizon Kinetics Medical ETF | USD 35.49 | ▲ 1.41% |
| GNTA | Genenta Science S.p.A. | USD 1.59 | ▼ 3.05% |
| DSCO | DoubleLine Securitized Credit E | USD 24.76 | ▼ 0.04% |
| PRCS | Parnassus Core Select ETF | USD 27.91 | ▼ 0.55% |
| IEMG | iShares Core MSCI Emerging Mark | USD 77.05 | ▼ 2.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 20:24 UTC. This page is informational and not investment advice.